Abstract
Nicotine dependence is a psychiatric disorder characterized by a recurrent, periodic compulsion to use tobacco due to neurophysiological, psychological, and social factors. This disorder has behavioral and physiological characteristics that are similar to those of other addictions, but also unique aspects that require special attention because of its ubiquity on a global scale, its staggering effects on rates of morbidity and mortality, and its high prevalence of psychological comorbidities, including psychiatric disorders. Our chapter focuses on the epidemiology of comorbid nicotine dependence and psychiatric disorders, the underlying biobehavioral mechanisms of comorbidity, cultural factors, psychiatric disorders most often associated with nicotine dependence, and treatment approaches. While there is a need for ongoing studies to more clearly delineate the best treatment interventions for persons with comorbid psychiatric disorders and nicotine dependence, the evidence to date suggests use of all of the medication, behavioral, and peer-support approaches available. Culture changes are needed in mental health and addiction treatment settings to continue to improve access to effective interventions for persons with nicotine dependence and psychological comorbidities.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acton, G. S., Prochaska, J. J., Kaplan, A. S., Small, T., & Hall, S. M. (2001). Depression and stages of change for smoking in psychiatric outpatients. Addictive Behaviors, 26, 621–631.
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992). Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biological Psychiatry, 32, 607–616.
Adler, L. E., Hoffer, L. D., Wiser, A., & Freedman, R. (1993). Normalization of auditory physiology by cigarette smoking in schizophrenic patients. The American Journal of Psychiatry, 150, 1856–1861.
Agrawal, A., Pergadia, M. L., Saccone, S. F., Hinrichs, A. L., Lessov-Schlaggar, C. N., Saccone, N. L., et al. (2008). Gamma-aminobutyric acid receptor genes and nicotine dependence: Evidence for association from a case-control study. Addiction, 103, 1027–1038.
Aguilar, M. C., Gurpegui, M., Diaz, F. J., & de Leon, J. (2005). Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions. The British Journal of Psychiatry, 186, 215–221.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Washington: American Psychiatric Association.
Backer, T. E. (1995). Assessing and enhancing readiness for change: Implications for technology transfer. In T. E. Backer, S. L. David, & G. Saucy (Eds.), Reviewing the behavioral science knowledge base on technology transfer. NIDA Research Monograph 155. Rockville: National Institute on Drug Abuse.
Barnes, M., Lawford, B. R., Burton, S. C., Heslop, K. R., Noble, E. P., Hausdorf, K., et al. (2006). Smoking and schizophrenia: Is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? The Australian and New Zealand Journal of Psychiatry, 40, 575–580.
Barr, R. S., Pizzagalli, D. A., Culhane, M. A., Goff, D. C., & Evins, A. E. (2008). A single dose of nicotine enhances reward responsiveness in nonsmokers: Implications for development of dependence. Biological Psychiatry, 63, 1061–1065.
Beckham, J. C., Dennis, M. F., McClernon, F. J., Mozley, S. L., Collie, C. F., & Vrana, S. R. (2007). The effects of cigarette smoking on script-driven imagery in smokers with and without posttraumatic stress disorder. Addictive Behaviors, 32, 2900–2915.
Beckham, J. C., Feldman, M. E., Vrana, S. R., Mozley, S. L., Erkanli, A., Clancy, C. P., et al. (2005). Immediate antecedents of cigarette smoking in smokers with and without posttraumatic stress disorder: A preliminary study. Experimental and Clinical Psychopharmacology, 13, 219–228.
Beckham, J. C., Kirby, A. C., Feldman, M. E., Hertzberg, M. A., Moore, S. D., Crawford, A. L., et al. (1997). Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addictive Behaviors, 22, 637–647.
Benowitz, N. L., Hukkanen, J., & Jacob, P., III. (2009). Nicotine chemistry, metabolism, kinetics, and biomarkers. In J. E. Henningfield et al. (Eds.), Nicotine psychopharmacology. Handbook of Experimental Pharmacology 192. Berlin: Springer.
Berg, J. Z., Mason, J., Boettcher, A. J., Hatsukami, D. K., & Murphy, S. E. (2010). Nicotine metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype. The Journal of Pharmacology and Experimental Therapeutics, 332, 202–209.
Bobo, J. K., Anderson, J. R., & Bowman, A. (1997). Training chemical dependency counselors to treat nicotine dependence. Addictive Behaviors, 22, 23–30.
Bobo, J. K., McIlvain, H. E., Lando, H. A., Walker, R. D., & Leed-Kelly, A. (1998). Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial. Addiction, 93, 877–887.
Borrelli, B., McQuaid, E. L., Novak, S. P., Hammond, S. K., & Becker, B. (2010). Motivating Latino caregivers of children with asthma to quit smoking: a randomized trial. Journal of Consulting and Clinical Psychology, 78, 34–43.
Boscarino, J. A. (2006). Posttraumatic stress disorder and mortality among U.S. Army veterans 30 years after military service. Annals of Epidemiology, 16, 248–256.
Breslau, N., & Klein, D. F. (1999). Smoking and panic attacks: An epidemiologic investigation. Archives of General Psychiatry, 56, 1141–1147.
Brody, A. L., Mandelkern, M. A., Jarvik, M. E., Lee, G. S., Smith, E. C., Huang, J. C., et al. (2004). Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biological Psychiatry, 55, 77–84.
Brown, S., & Barraclough, B. (2000). Causes of the excess mortality of schizophrenia. The British Journal of Psychiatry, 177, 212–217.
Burling, T. A., Burling, A. S., & Latini, D. (2001). A controlled smoking cessation trial for substance dependent inpatients. Journal of Consulting and Clinical Psychology, 69, 295–304.
Carney, R. M., Freedland, K. E., Miller, G. E., & Jaffe, A. S. (2002). Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. Journal of Psychosomatic Research, 53, 897–902.
Castellsaguè, X., Muñoz, N., De Stefani, E., Victora, C. G., Castelletto, R., Rolón, P. A., et al. (1999). Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. International Journal of Cancer, 82, 657–664.
Castro, Y., Reitzel, L. R., Businelle, M. S., Kendzor, D. E., Mazas, C. A., Li, Y., et al. (2009). Acculturation differentially predicts smoking cessation among Latino men and women. Cancer Epidemiology, Biomarkers & Prevention, 18, 3468–3475.
Centers for Disease Control and Prevention. (2002). Annual smoking-attributable mortality, years of potential life lost, and economic costs – United States, 1995–1999. Morbidity and Mortality Weekly Report, 51, 300–303.
Centers for Disease Control and Prevention. (2004). Prevalence of cigarette use among 14 racial/ethnic populations: United States 1999–2001. Morbidity and Mortality Weekly Report, 53(3), 49–52.
Chen, M. S. (2001). The status of tobacco cessation research for Asian Americans and Pacific Islanders. Asian American and Pacific Islander Journal of Health, 9, 61–65.
Connor, J. P., Young, R. M., Lawford, B. R., Saunders, J. B., Ritchie, T. L., & Noble, E. P. (2007). Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphism. Addictive Behaviors, 32, 310–319.
Cooney, N. L., Litt, M. D., & Cooney, J. L. (2002). In vivo assessment of the effects of smoking cessation in alcoholic smokers. Alcoholism, Clinical and Experimental Research, 26, 1952–1953.
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998). Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. The American Journal of Psychiatry, 155, 1490–1501.
De Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135–157.
Desai, H. D., Seabolt, J., & Jann, M. W. (2001). Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs, 15, 469–494.
Dickerson, D. L., O’Malley, S. S., Canive, J., Thuras, P., & Westermeyer, J. (2009). Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans. Drug and Alcohol Dependence, 99(1–3), 169–175.
DiFranza, J., Ursprung, W. W., Lauzon, B., Bancej, C., Wellman, R. J., Ziedonis, D., et al. (2010). A systematic review of the diagnostic and statistical manual diagnostic criteria for nicotine dependence. Addictive Behaviors (Epub 2009 Dec 21), 35(5), 373–382.
Dodd, S., Brnabic, A. J., Berk, L., Fitzgerald, P. B., de Castella, A. R., Filia, S. (2010). A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Comprehensive Psychiatry, 51, 504–509.
Ehringer, M. A., Clegg, H. V., Collins, A. C., Corley, R. P., Crowley, T., Hewitt, J. K., et al. (2007). Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 596–604.
el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2002). Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatric Services, 53(9), 1166–1170.
Evins, E. A., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M. A., Olm-Shipman, C. M., et al. (2005). A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25, 218–225.
Evins, A. E., Culhane, M. A., Alpert, J. E., Pava, J., Liese, B. S., Farabaugh, A., et al. (2008). A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology, 28, 660–668.
Evins, A., Mays, V., Cather, C., Rigotti, N., Tisdale, T., & Goff, D. (2001). A pilot trial of sustained release bupropion added to cognitive behavioral group therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research, 3, 391–396.
Falk, D. E., Yi, H. Y., & Hiller-Sturmhofel, S. (2006). An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: Findings from the National Epidemiologic Survey on alcohol and related conditions. Alcohol Research & Health, 29(3), 162–171.
Feldner, M. T., Babson, K. A., & Zvolensky, M. J. (2007). Smoking, traumatic event exposure, and posttraumatic stress: A critical review of the empirical literature. Clinical Psychology Review, 27, 14–45.
Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry S. J., et al. (2008). Treating tobacco use and dependence, 2008 Update. Clinical Practice Guideline. Rockville: U.S. Department of Health and Human Services. Public Health Service.
Forchuk, C., Norman, R., Malla, A., Martin, M., McLean, T., Cheng, S., et al. (2002). Schizophrenia and the motivation for smoking. Perspectives in Psychiatry, 38, 41–46.
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., et al. (1997). Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proceedings of the National Academy of Sciences, 94, 587–592.
Freedman, R., Leonard, S., Olincy, A., Kaufmann, C. A., Malaspina, D., Cloninger, C. R., et al. (2001). Evidence for the multigenic inheritance of schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 105, 794–800.
Friend, K. B., & Pagano, M. E. (2005). Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. Journal of Addictive Diseases, 24, 61–75.
Gardner, P. D., Tapper, A. R., King, J. A., & Ziedonis, D. M. (2009). The neurobiology of nicotine addiction: Clinical and public policy implications. Journal of Drug Issues, 39, 1045–1067.
George, T. P., Vessicchio, J. C., Termaine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53–61.
George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. The American Journal of Psychiatry, 157, 1835–1842.
Goodwin, R. D., & Hamilton, S. P. (2002). The early-onset fearful panic attack as a predictor of severe psychopathology. Psychiatry Research, 109, 71–79.
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004). Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 1107–1115.
Guydish, J., Ziedonis, D., Tajima, B., Brigham, G., Zammarelli, L., & Levy, M. (2009). Addressing nicotine dependence in drug treatment settings: Organizational change. Poster session presented at the annual meeting of the College on Problems of Drug Dependence, Reno.
Hahn, L. P., Folsom, A. R., Sprafka, J. M., & Norsted, S. W. (1990). Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Reports, 105, 290–295.
Hall, S. M., Humfleet, G. L., Reus, V. I., Munoz, R. F., & Cullen, J. (2004). Extended nortriptyline and psychological treatment for cigarette smoking. The American Journal of Psychiatry, 161, 2100–2107.
Hall, S. M., Munoz, R. F., & Reus, V. I. (1994). Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting and Clinical Psychology, 62, 141–146.
Hall, S. M., Reus, V. I., Munoz, R. F., Sees, K. L., Humfleet, G., Hartz, E., et al. (1998). Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry, 55, 683–690.
Hall, S. M., Sees, K. L., Munoz, R. F., Reus, V. I., Duncan, C., Humfleet, G. L., et al. (1996). Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo controlled study. Journal of Consulting and Clinical Psychology, 64, 1003–1009.
Heyman, K. M., Barnes, P. M., & Schiller, J. S. (2009). Early release of selected estimates based on data from the 2008 National Health Interview Survey. Hyattsville: National Center for Health Statistics.
Hoffman, A. L., & Slade, J. (1993). Following the pioneers: Addressing tobacco in chemical dependency treatment. Journal of Substance Abuse Treatment, 10, 153–160.
Hughes, J. R. (2007a). Depression during tobacco abstinence. Nicotine & Tobacco Research, 9, 443–446.
Hughes, J. R. (2007b). Effects of abstinence from tobacco: Etiology, animal models, epidemiology, and significance: A subjective review. Nicotine & Tobacco Research, 9, 329–339.
Hurt, R. D., Offord, K. P., Croghan, I. T., Gomez-Dahl, L., Kotkke, T. E., Morse, R. M., et al. (1996). Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. Journal of the American Medical Association, 275, 1097–1103.
Irving, L. M., Seidner, A. L., Burling, T. A., Thomas, R. G., & Brenner, G. F. (1994). Drug and alcohol inpatients’ attitudes about smoking cessation. Journal of Substance Abuse, 6, 267–278.
Jenkins, C. N., McPhee, S. J., Le, A., Pham, G. Q., Ha, N. T., & Stewart, S. (1997). The effectiveness of a media-led intervention to reduce smoking among Vietnamese-American men. American Journal of Public Health, 87(6), 1031–1034.
Joseph, A. M., Willenbring, M. L., Nugent, S. M., & Nelson, D. B. (2004). A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol, 65, 681–691.
Juon, H. S., Kim, M., Han, H., Ryu, J. P., & Han, W. (2003). Acculturation and cigarette smoking among Korean American men. Yonsei Medical Journal, 4, 875–882.
Kabat, G. C., Morabia, A., & Wynder, E. L. (1991). Comparison of smoking habits of blacks and whites in a case-control study. American Journal of Public Health, 81(11), 1483–1486.
Kalman, D. (2002). The subjective effects of nicotine on humans: Methodological issues, a review of human laboratory studies and recommendations for future research. Nicotine & Tobacco Research, 4, 25–70.
Kalman, D., Kahler, C., Garvey, A. J., & Monti, P. M. (2006). High dose nicotine patch therapy for smokers with a past history of alcohol dependence: 36 week outcomes. Journal of Substance Abuse Treatment, 30, 213–217.
Kalman, D., Kim, S., DiGirolamo, G., Smelson, D., & Ziedonis, D. (2010). Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review., 30(1), 12–24.
Kalman, D. A., Morissette, S. B., & George, T. P. (2005). Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions, 14, 106–123.
Kalman, D., Rohsenow, D., Colby, S., Hayes, K., & Monti, P. M. (2001). Concurrent vs. delayed smoking cessation treatment for alcoholics in early recovery: A pilot study. Journal of Substance Abuse Treatment, 20, 233–238.
Kendler, K. S., Neale, M. C., Sullivan, P., Corey, L. A., Gardner, C. O., & Prescott, C. A. (1999). A population-based twin study in women of smoking initiation and nicotine dependence. Psychological Medicine, 29, 299–308.
Killen, J. D., Fortmann, S. P., Schatzberg, A., Hayward, C., & Varady, A. (2003). Onset of major depression during treatment for nicotine dependence. Addictive Behaviors, 28, 461–470.
Kim, K. K., Yu, E. S. H., Chen, E. H., Kim, J., Brintnall, R., & Vance, S. (2000). Smoking behavior, knowledge, and beliefs among Korean Americans. Cancer Practice, 8, 223–230.
Kim, S. S., Ziedonis, D., & Chen, K. W. (2007). Tobacco use and dependence in Asian Americans: A review of the literature. Nicotine & Tobacco Research, 9, 169–184.
Kirch, D. G., Alho, A., & Wyatt, R. J. (1988). Hypothesis: A nicotine-dopamine interaction linking smoking with Parkinson’s disease and tardive disease. Cellular and Molecular Neurobiology, 8, 285–291.
Kleber, H. D., Weiss, R. D., Anton, R. F., Rounsaville, B. J., George, T. P., Strain, E. C., et al. (2006). Greenfield, S.F., Ziedonis, D. M., Kosten, T. R., Hennessy, G., O’Brien, C. P., Connery, H.S. American Psychiatric Association Steering Committee on Practice Guidelines; McIntyre, J. S., Charles, S. C., Anzia, D. J., Nininger, J. E., Cook, I. A., Summergrad, P., Finnerty, M. T., Woods, S. M., Johnson, B. R., Yager, J., Pyles, R., Lurie, L., Cross, C. D., Walker, R. D., Peele, R., Barnovitz, M. A., Gray, S. H., Shemo, J. P., Saxena, S., Tonnu, T., Kunkle, R., Albert, A. B., Fochtmann, L. J., Hart, C., Regier, D. Treatment of patients with substance use disorders, second edition. American Journal of Psychiatry, 163, 5–82.
Klesges, R. C., Klesges, L. M., Myers, A. W., Klem, M. L., & Isbell, T. (1990). The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation. Clinical Pharmacology and Therapeutics, 47, 747–754.
Koenen, K. C., Hitsman, B., Lyons, M. J., Niaura, R., McCaffery, J., Goldberg, J., et al. (2005). A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Archives of General Psychiatry, 62, 1258–1265.
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. The Journal of the American Medical Association, 284, 2606–2610.
Leshnar, A. I., & Koob, G. F. (1999). Drugs of abuse and the brain. Proceedings of the Association of American Physicians, 111, 99–108.
Lettlow, H. (2004). Commentary on Smoking Cessation in U.S. Ethnic Minority Populations. VA in the Vanguard: Building on Success in Smoking Cessation. Proceeding of a Conference Held September 21, 2004. San Francisco.
Lew, R., Moskowitz, J. M., Wismer, B. A., Min, K., Kang, S. H., Chen, A. M., et al. (2001). Correlates of cigarette smoking among Korean American adults in Alameda County, California. Asian American and Pacific Islander Journal of Health, 19, 50–60.
Li, T. K., Volkow, N. D., Baler, R. D., & Egli, M. (2007). The biological bases of nicotine and alcohol co-addiction. Biological Psychiatry, 61, 1–3.
Lyons, M. J., Bar, J. L., Kremen, W. S., Toomey, R., Eisen, S. A., Goldberg, J., et al. (2002). Nicotine and familial vulnerability to schizophrenia: A discordant twin study. Journal of Abnormal Psychology, 111, 687–693.
Ma, G. X., Fang, C., Shive, S., Su, X., Toubbeh, J. I., Miller, S., et al. (2005). A culturally enhanced smoking cessation study among Chinese and Korean smokers. The International Journal of Health Education, 8, 1–10.
McCaffery, J. M., Papandonatos, G. D., Stanton, C., Lloyd-Richardson, E. E., & Niaura, R. (2008). Depressive symptoms and cigarette smoking in twins from the National Longitudinal Study of Adolescent Health. Health Psychology, 3, S207–S215.
McClernon, F. J., Beckham, J. C., Mozley, S. L., Feldman, M. E., Vrana, S. R., & Rose, J. E. (2004). The effects of trauma recall on smoking topography in posttraumatic stress disorder and non-posttraumatic stress disorder trauma survivors. Addictive Behaviors, 30, 247–257.
McFall, M., Atkins, D. C., Yoshimoto, D., Thompson, C. E., Kanter, E., Malte, C. A., et al. (2006). Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder. The American Journal on Addictions, 15, 336–344.
McFall, M., Saxon, A. J., Thompson, C. E., Yoshimoto, D., Malte, C., Straits-Troster, K., et al. (2005). Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. The American Journal of Psychiatry, 162, 1311–1319.
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford Press.
Monti, P. M., Rohsenow, D. J., Colby, S. M., & Abrams, D. B. (1995). Smoking among alcoholics during and after treatment: Implications for models, treatment strategies, and policy. In J. B. Fertig & J. P. Allen (Eds.), Alcohol and tobacco: From basic science to clinical practice. NIAAA Research Monograph No. 30 (pp. 187–206). Bethesda: National Institutes on Health.
Morris, C. D., Giese, A. A., Turnbull, J. J., Dickinson, M., & Johnson-Nagel, N. (2006). Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatric Services, 57, 1035–1038.
Okuyemi, K. S., Sanderson, C. L., Cho, W. S., & Ahluwalia, J. S. (2004). Smoking Cessation in U.S. Ethnic Minority Populations. VA in the Vanguard: Building on Success in Smoking Cessation. Proceeding of a Conference Held September 21, 2004. San Francisco.
Olincy, A., Young, D. A., & Freedman, R. (1997). Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry, 42, 1–5.
Orleans, C. T., & Hutchinson, D. (1993). Tailoring nicotine addiction treatments for chemical dependency. Journal of Substance Abuse Treatment, 9, 197–208.
Perkins, K. A., Ciccocioppo, M., Conklin, C. A., & Milanak, M. E. (2008). Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. Journal of Abnormal Psychology, 117, 79–93.
Picciotto, M. R., Addy, N. A., Mineur, Y. S., & Brunzell, D. H. (2008). It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Progress in Neurobiology, 84, 329–342.
Picciotto, M. R., & Zoli, M. (2008). Neuroprotection via nAChRs: The role of nAChRs in neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Frontiers in Bioscience, 13, 492–504.
Prochaska, J. J., Delluchi, K., & Hall, S. M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72, 1144–1156.
Prochaska, J. J., Hall, S. M., Tsoh, J. Y., Eisendrath, S., Rossi, J. S., Redding, C. A., et al. (2008). Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. American Journal of Public Health, 98(3), 446–448.
Prochaska, J. O., Velicer, W. F., Fava, J. L., Rossi, J. S., & Tsoh, J. Y. (2001). Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addictive Behaviors, 26, 583–602.
Ray, R., Jepson, C., Patterson, F., Strasser, A., Rukstalis, M., Perkins, K., et al. (2006). Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology, 188, 355–363.
Rogers, T., Feighery, E. C., Tencati, E. M., Butler, J. L., & Weiner, L. (1995). Community mobilization to reduce point of purchase advertising of tobacco products. Health Education Quarterly, 22, 427–442.
Rohsenow, D. J., Colby, S. M., Martin, R. A., & Monti, P. M. (2005). Nicotine and other substance interaction expectancies questionnaire: Relationship of expectancies to substance use. Addictive Behaviors, 30, 629–641.
Rohsenow, D. J., Monti, P. M., Colby, S. M., & Martin, R. A. (2002). Brief interventions for smoking cessation in alcoholic smokers. Alcoholism, Clinical and Experimental Research, 26, 1950–1951.
Rustin, T. A. (1998). Incorporating nicotine dependence into addiction treatment. Journal of Addictive Diseases, 17, 83–108.
Schroeder, S. A., & Morris, C. D. (2010). Confronting a neglected epidemic: Tobacco cessation for persons with mental illnesses and substance abuse problems. Annual Review of Public Health, 31, 297–314.
Sharp, J., Schwartz, S., Nightingale, T., & Novak, S. (2003). Targeting nicotine addiction in a substance abuse program. Science & Practice Perspectives, 2, 33–40.
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002). Nicotinic acetylcholine receptors as targets for antidepressants. Molecular Psychiatry, 7, 525–535.
Smith, J. E., Meyers, R. J., & Miller, W. R. (2001). The community reinforcement approach to the treatment of substance use disorders. Addiction, 10(Suppl), 51–59.
Sonne, S. C., Nunes, E. V., Jiang, H., Tyson, C., Rotrosen, J., & Reid, M. S. (2010). The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. The American Journal on Addictions, 19, 111–118.
Spring, B., Pingitore, R., & McChargue, D. E. (2003). Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. The American Journal of Psychiatry, 160, 316–322.
Srinivasan, T. N., & Thara, R. (2002). Smoking in Schizophrenia – all is not biological. Schizophrenia Research, 56(1–2), 67–74.
Stark, M. J., & Campbell, B. K. (1993). Drug use and cigarette smoking in applicants for drug abuse treatment. Journal of Substance Abuse, 5, 175–181.
Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723–728.
Sullivan, P. F., & Kendler, K. S. (1999). The genetic epidemiology of smoking. Nicotine & Tobacco Research, 1, S69–S70.
Thridandam, M., Fong, W., Jang, M., Louie, L., & Forst, M. (1998). A tobacco and alcohol use profile of San Francisco’s Chinese community. Journal of Drug Education, 28, 377–393.
True, W. R., Xian, H., Scherrer, J. F., Madden, P. A. F., Bucholz, K. K., Heath, A. C., et al. (1999). Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry, 56, 655–661.
Vanable, P. A., Carey, M. P., Carey, K. B., & Maisto, S. P. (2003). Smoking among psychiatric outpatients: Relationship to substance use, diagnosis, and illness severity. Psychology of Addictive Behaviors, 17, 259–265.
Waxmonsky, J. A., Thomas, M. R., Miklowitz, D. J., Allen, M. H., Wisniewski, S. R., Zhang, H.(2005). Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. General Hospital Psychiatry, 27, 321–328.
Wiecha, J. M., Lee, V., & Hodgkins, J. H. (1998). Patterns of smoking, risk factors for smoking, and smoking cessation among Vietnamese men in Massachusetts (United States). Tobacco Control, 7, 27–34.
Williams, J. M., Foulds, J., Dwyer, M., Order-Connors, B., Springer, M., Gadde, P., et al. (2005). The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. Journal of Substance Abuse Treatment, 28(4), 331–340.
Williams, J. M., Gandhi, K. K., Steinberg, M. L., Foulds, J., Ziedonis, D. M., & Benowitz, N. L. (2007). Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine & Tobacco Research, 9(8), 873–881.
Williams, J. M., & Ziedonis, D. M. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067–1083.
Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). Case series of nicotine nasal spray in the combination treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55(9), 1064–1066.
Williams, J., Ziedonis, D. M., Vreeland, B., Speelman-Edwards, N., Zechner, M. R., Williams, M. T., et al. (2009). A wellness approach to addressing tobacco in mental health settings: Learning about healthy living. American Journal of Psychiatric Rehabilitation., 12(4), 352–369.
World Health Organization. (2009). Who report on the global tobacco epidemic 2009: Implementing smoke-free environments. Geneva: World Health Organization.
Wu, L. T., & Anthony, J. C. (1999). Tobacco smoking and depressed mood in late childhood and early adolescence. American Journal of Public Health, 89, 1837–1840.
Wu, D., Ma, G. X., Zhou, K., Zhou, D., Liu, A., & Poon, A. N. (2009). The effect of a culturally tailored smoking cessation for Chinese American smokers. Nicotine & Tobacco Research, 11(12), 1448–1457.
Yu, E. S., Chen, E. H., Kim, K. K., & Abdulrahim, S. (2002). Smoking among Chinese Americans: Behavior, knowledge, and beliefs. American Journal of Public Health, 92, 1007–1012.
Zevin, S., & Benowitz, N. L. (1999). Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics., 36, 425–438.
Zheng, T. Z., Boyle, P., Hu, H. F., Duan, J., Jiang, P. J., Ma, D. Q., et al. (1990). Tobacco smoking, alcohol consumption and risk of oral cancer: a case-control study in Beijing, People’s Republic of China. Cancer Causes & Control, 1, 173–179.
Zhou, S.-F. (2009). Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clinical Pharmacokinetics, 48, 689–723.
Ziedonis, D. M., Guydish, J., Williams, J., Steinberg, M., & Foulds, J. (2006). Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Research & Health, 29, 228–235.
Ziedonis, D. M., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., et al. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health Report. Nicotine & Tobacco Research, 10, 1691–1715.
Ziedonis, D. M., Kalman, D., Johnson, C.W., & Mistler, L. A. (in press). Nicotine dependence management. In Lowinson & Ruiz (Eds.), Substance abuse: A comprehensive textbook (5th ed.). Baltimore: Lippincott Williams & Wilkins.
Ziedonis, D. M., Kosten, T. R., Glazer, W. M., & Frances, R. J. (1994). Nicotine dependence and schizophrenia. Hospital & Community Psychiatry, 45, 204–206.
Ziedonis, D. M., Williams, J. M., & Smelson, D. (2003). Serious mental illness and tobacco addiction: A model program to address this common but neglected issue. The American Journal of the Medical Sciences, 326, 223–230.
Zvolensky, M. J., & Bernstein, A. (2005). Cigarette smoking and panic psychopathology. Current Directions in Psychological Science, 14, 301–305.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ziedonis, D., Kalman, D., Kolodziej, M., Johnson, C.W., Kim, S. (2011). Tobacco Addiction and Psychological Co-morbidities. In: Pagoto, S. (eds) Psychological Co-morbidities of Physical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0029-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0029-6_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0030-2
Online ISBN: 978-1-4419-0029-6
eBook Packages: MedicineMedicine (R0)